解读替代拼接在瘤疾病中的作用,用于免疫瘤疗法
Marcus Bauer1, Chiara-Maria Schöbel2, Claudia Wickenhauser1
1Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Frontiers in immunology
|May 13, 2024
概括
替代拼接产生癌症点的变体,影响免疫治疗的有效性. 分析拼接模式可以改善患者选择和治疗策略,以获得更好的结果.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 替代拼接 (AS) 是一种影响基因表达的关键分子机制.
- AS是组织特异性的,在包括癌症在内的各种疾病中受到失调.
- 像单克隆抗体 (mAbs) 和仿真抗原受体 (CAR) T 细胞这样的免疫瘤疗法具有前景,但在许多患者中有效性有限.
研究的目的:
- 审查替代拼接在癌症中的作用及其对免疫治疗的影响.
- 探索AS的分子机制及其临床相关性.
- 讨论AS分析对改善癌症治疗反应的潜力.
主要方法:
- 关于替代拼接机制及其在癌症中的作用的文献综述.
- 分析拼接变种如何影响免疫疗法的疗效 (mAbs,CAR T细胞).
- 在癌症患者中检查拼接因子的预后潜力.
主要成果:
- 替代拼接产生免疫治疗标的拼接变体,导致免疫逃避和降低治疗疗效.
- 目标分子的拼接模式可以影响患者的分层和治疗反应.
- 某些拼接因素与患者的结果相关,这表明预后价值.
结论:
- 了解替代拼接对于优化癌症免疫治疗至关重要.
- 分析瘤中的拼接模式可能使更好的患者选择和个性化治疗策略成为可能.
- 需要进一步的研究来将AS发现转化为临床应用,以改善癌症患者的治疗结果.
相关概念视频
RNA Splicing
56.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
What is Gene Expression?
8.5K
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then...
8.5K
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Pre-mRNA Processing: RNA Splicing
5.2K
5.2K


